H Echizen
Impact in
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Antibiotics Pharmacokinetics and Efficacy
-
- Drug Transport and Resistance Mechanisms
Papers in
-
- Pharmaceutical studies and practices 3
- Pharmacological Effects and Toxicity Studies 3
-
- Pharmacogenetics and Drug Metabolism 5
- Co-authors
- Michel F Eichelbaum (3 shared papers)Takashi Ishizaki (14 shared papers)Harumi Takahashi (4 shared papers)Barbara Vogelgesang (1 shared paper)Elke Schmidt (1 shared paper)Kazuhiro Chiba (7 shared papers)Masaharu Tani (3 shared papers)Katsuhiko Yoshimoto (1 shared paper)
In The Last Decade
H Echizen
32 papers receiving 806 citations
Peers
Comparison fields: 5 of 92
- Pharmacology 383
- Oncology 227
- Spectroscopy 136
- Pediatrics, Perinatology and Child Health 128
- Pharmacology 113
Countries citing papers authored by H Echizen
This map shows the geographic impact of H Echizen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Echizen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Echizen more than expected).
Fields of papers citing papers by H Echizen
This network shows the impact of papers produced by H Echizen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Echizen. The network helps show where H Echizen may publish in the future.
Co-authors
The 25 scholars most cited alongside H Echizen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1984 | 164 | |
| 2 | 1995 | 108 | |
| 3 | 2003 | 83 | |
| 4 | 1992 | 78 | |
| 5 | 1988 | 64 | |
| 6 | 2002 | 40 | |
| 7 | 1982 | 38 | |
| 8 | 1994 | 36 | |
| 9 | Dihydropyridine type calcium channel blocker-induced turbid dialysate in patients undergoing peritoneal dialysis. | 1998 | 33 |
| 10 | 1993 | 33 | |
| 11 | 1999 | 24 | |
| 12 | 1989 | 21 | |
| 13 | A drug-induced turbid peritoneal dialysate in five patients treated with continuous ambulatory peritoneal dialysis. | 1993 | 20 |
| 14 | 1986 | 18 | |
| 15 | 1983 | 16 | |
| 16 | 2002 | 13 | |
| 17 | 1990 | 10 | |
| 18 | 1991 | 8 | |
| 19 | The interrelation of urinary calcium and sodium intake in healthy elderly Japanese. | 1991 | 8 |
| 20 | 1994 | 8 |
About H Echizen
H Echizen is a scholar working on Pediatrics, Perinatology and Child Health, Pharmacology, Clinical Biochemistry, Biochemistry and Physiology, having authored 32 papers that have together received 873 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (5 papers), Metabolism and Genetic Disorders (4 papers), Pharmaceutical studies and practices (3 papers), Pharmacological Effects and Toxicity Studies (3 papers), Receptor Mechanisms and Signaling (3 papers), Analytical Chemistry and Chromatography (2 papers), Metabolomics and Mass Spectrometry Studies (2 papers) and Asthma and respiratory diseases (2 papers). The work is most often cited by research in Pharmacology (383 citations), Oncology (227 citations), Spectroscopy (136 citations), Pediatrics, Perinatology and Child Health (128 citations) and Pharmacology (113 citations). H Echizen has collaborated with scholars based in Japan, Germany and Austria. Frequent co-authors include Michel F Eichelbaum, Takashi Ishizaki, Harumi Takahashi, Barbara Vogelgesang, Elke Schmidt, Kazuhiro Chiba, Masaharu Tani, Katsuhiko Yoshimoto, Markus Gabriel Manz and Hugo Th. Heidemann. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, British Journal of Clinical Pharmacology, European Journal of Clinical Pharmacology, Clinical Chemistry and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.